Kassis-Chikhani N - Search Results

1

Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.

Fournier S, Brossier F, Fortineau N, Gillaizeau F, Akpabie A, Aubry A, Barbut F, Chedhomme FX, Kassis-Chikhani N, Lucet JC, Robert J, Seytre D, Simon I, Vanjak D, Zahar JR, Brun-Buisson C, Jarlier V. Fournier S, et al. Euro Surveill. 2012 Jul 26;17(30):20229. Euro Surveill. 2012. PMID: 22856512 Free article.

2

Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004.

Kassis-Chikhani N, Saliba F, Carbonne A, Neuville S, Decre D, Sengelin C, Guerin C, Gastiaburu N, Lavigne-Kriaa A, Boutelier C, Arlet G, Samuel D, Castaing D, Dussaix E, Jarlier V. Kassis-Chikhani N, et al. Euro Surveill. 2010 Nov 18;15(46):19713. doi: 10.2807/ese.15.46.19713-en. Euro Surveill. 2010. PMID: 21144428 Free article.

3

Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009.

Carbonne A, Thiolet JM, Fournier S, Fortineau N, Kassis-Chikhani N, Boytchev I, Aggoune M, Seguier JC, Senechal H, Tavolacci MP, Coignard B, Astagneau P, Jarlier V. Carbonne A, et al. Euro Surveill. 2010 Dec 2;15(48):19734. doi: 10.2807/ese.15.48.19734-en. Euro Surveill. 2010. PMID: 21144448 Free article.

4

Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study.

Nicolas-Chanoine MH, Jarlier V, Robert J, Arlet G, Drieux L, Leflon-Guibout V, Laouénan C, Larroque B, Caro V, Mentré F; Group Coli β. Nicolas-Chanoine MH, et al. PLoS One. 2012;7(1):e30498. doi: 10.1371/journal.pone.0030498. Epub 2012 Jan 27. PLoS One. 2012. PMID: 22299043 Free PMC article.

5

Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes.

Brisse S, Diancourt L, Laouénan C, Vigan M, Caro V, Arlet G, Drieux L, Leflon-Guibout V, Mentré F, Jarlier V, Nicolas-Chanoine MH; Coli β Study Group. Brisse S, et al. J Clin Microbiol. 2012 Sep;50(9):2974-81. doi: 10.1128/JCM.00919-12. Epub 2012 Jul 3. J Clin Microbiol. 2012. PMID: 22760036 Free PMC article.

6

Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution.

Fournier S, Lepainteur M, Kassis-Chikhani N, Huang M, Brun-Buisson C, Jarlier V; AP-HP Outbreaks Control Group. Fournier S, et al. J Travel Med. 2012 Sep-Oct;19(5):320-3. doi: 10.1111/j.1708-8305.2012.00641.x. Epub 2012 Aug 1. J Travel Med. 2012. PMID: 22943275 Free article.

7

Complete nucleotide sequence of the first KPC-2- and SHV-12-encoding IncX plasmid, pKpS90, from Klebsiella pneumoniae.

Kassis-Chikhani N, Frangeul L, Drieux L, Sengelin C, Jarlier V, Brisse S, Arlet G, Decré D. Kassis-Chikhani N, et al. Antimicrob Agents Chemother. 2013 Jan;57(1):618-20. doi: 10.1128/AAC.01712-12. Epub 2012 Oct 22. Antimicrob Agents Chemother. 2013. PMID: 23089759 Free PMC article.

8

Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France.

Dortet L, Glaser P, Kassis-Chikhani N, Girlich D, Ichai P, Boudon M, Samuel D, Creton E, Imanci D, Bonnin R, Fortineau N, Naas T. Dortet L, et al. J Antimicrob Chemother. 2018 Jan 1;73(1):41-51. doi: 10.1093/jac/dkx370. J Antimicrob Chemother. 2018. PMID: 29092052 Free PMC article.

9

Controlling healthcare-associated transmission of SARS-CoV-2 variant of concern 202012/01 in a large hospital network.

Duverger C, Souyri V, Monteil C, Fournier S; AP-HP COVID-19 Infection Prevention and Control Group. Duverger C, et al. J Hosp Infect. 2021 Aug;114:182-184. doi: 10.1016/j.jhin.2021.04.031. Epub 2021 May 7. J Hosp Infect. 2021. PMID: 33965454 Free PMC article. No abstract available.

10

Faecal carriage of multidrug-resistant bacteria and associated risk factors: results from a point prevalence study.

Grohs P, Vilfaillot A, Zahar JR, Barbut F, Frange P, Casetta A, Moulin V, Lawrence C, Baune P, Bourgeois C, Bouffier A, Laussucq C, Sienzonit L, Picard S, Podglajen I, Kassis-Chikhani N. Grohs P, et al. Among authors: kassis chikhani n. J Antimicrob Chemother. 2022 Sep 30;77(10):2667-2678. doi: 10.1093/jac/dkac289. J Antimicrob Chemother. 2022. PMID: 36031727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page